CHGB and Parkinson disease: In PD, disruption of the regulated secretory pathway may lead to CHGB being misdirected into exosomes or microvesicles instead of dense-core vesicles, with stressed neurons potentially enhancing CHGB-containing EV release as a compensatory response.